Stay updated on Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe revision label on the page updated from v3.6.2 to v3.6.3, indicating a new version of the page. It represents a system or template update rather than changes to trial details.SummaryDifference0.1%

- Check8 days agoChange DetectedFooter now displays Revision: v3.6.2, indicating a minor maintenance update to the page. There is no change to the study details or navigation.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedEnrollment has closed for this study ('No longer looking for participants'), reflecting termination of accrual. New user-help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) along with a minor header formatting change (Intervention/Treatment) and a revision note (Revision: v3.6.0).SummaryDifference0.6%

- Check30 days agoChange DetectedThe page revision tag has been updated from v3.5.4 to v3.5.5, indicating a new release of the page template or CMS. This update does not affect the study information displayed.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, signaling a site deployment. It does not change the study details or results, only the page's underlying version.SummaryDifference0.1%

- Check58 days agoChange DetectedNo changes detected for the page details; the study record remains as originally published.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab in Mucinous Tumors Clinical Trial page.